However, since Wallingford et al. discovered that PRCP is responsible for inactivating the anorexigenic peptide alpha-melanocyte stimulating hormone 1–13 (α-MSH 1–13), PRCP mainly received interest for its role in metabolic disorders [10,11,12,13,14]. The gene discussed is PRCP; the disease is metabolic disease.